NEW YORK (GenomeWeb) – Premaitha Health today reported a doubling of revenues for its fiscal year 2017, which ended March 31, and said that it has raised £2.5 million ($3.37 million) in new funding through a share subscription. The firm also provided an update on its business and on its patent litigation with Illumina.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.